The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma proteome-based integrative prognostic nomogram in metastatic castrate-resistant prostate cancer (mCRPC).
 
Manish Kohli
Employment - nference (I)
Stock and Other Ownership Interests - Atzeyo Biosensors; Cancer Healing Networks
Honoraria - Advanced Accelerator Applications
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Cytogen; Genapsys; Tempus
Patents, Royalties, Other Intellectual Property - Patent number: 10982286. Algorithmic approach for determining the plasma genome abnormality PGA and the urine genome abnormality UGA scores based on cell free cfDNA copy number variations in plasma and urine
Travel, Accommodations, Expenses - Celgene; Olink Proteomics INC
 
Joseph Finklestein
No Relationships to Disclose
 
Xingyue Huo
No Relationships to Disclose
 
Claire Hanson
No Relationships to Disclose
 
Matt Larsen
No Relationships to Disclose
 
Enos Ampaw
No Relationships to Disclose
 
Bogdana Schmidt
Consulting or Advisory Role - ImmunityBio; Urogen pharma
Speakers' Bureau - Ferring
 
Benjamin Maughan
Consulting or Advisory Role - Astellas Medivation; AVEO; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Janssen Oncology; Lilly; Merck; Peloton Therapeutics; Pfizer; Sanofi; Telix Pharmaceuticals; Tempus; Xencor
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Umang Swami
Consulting or Advisory Role - Adaptimmune; Astellas Pharma; AstraZeneca; Exelixis; Gilead Sciences; Imvax; Janssen Scientific Affairs; Pfizer; Sanofi; Seagen
Research Funding - Exelixis (Inst); Janssen (Inst); lava therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); ORIC Pharmaceuticals (Inst); Seagen (Inst); Seattle Genetics/Astellas (Inst)
 
Jonathan Tward
No Relationships to Disclose
 
Skyler Johnson
No Relationships to Disclose
 
Brock ONeil
No Relationships to Disclose
 
Christopher Dechet
No Relationships to Disclose
 
Liang Wang
No Relationships to Disclose
 
Aikchoon Tan
No Relationships to Disclose
 
Muhammad Hidayatullah Fadlullah
No Relationships to Disclose